The reflex response to industry funding is either to dismiss the study or to insist it makes no difference. Both are wrong, and the accurate position is duller and more useful.

Why funding shifts results without fraud

Industry-funded trials produce favourable results more often than independently funded ones, across many fields, and it is not usually because data were faked. The influence enters at earlier and more respectable points.

Which questions get asked. A company funds the studies most likely to help it, and does not fund the ones likely to hurt it. Every individual study can be honest while the body of evidence is shaped.

Comparator choice. Testing against nothing, or against a low dose of an alternative, produces a better result than a fair comparison, and is entirely legitimate methodologically.

Outcome selection. Measure several things, report the one that moved. Pre-registration exists to prevent this and is not universal.

Publication. The strongest lever of all. Unfavourable results are less likely to appear, and the decision not to publish leaves no trace anyone can audit.

What funding actually is

A reason to look harder, not a verdict. A well-designed, pre-registered, independently analysed industry trial can be better evidence than a sloppy independent one.

The conflicts nobody declares

Direct funding is the easy case because it is usually disclosed. Harder ones include a researcher who has built a public reputation on a hypothesis, an author with a book on the subject, a clinician selling a protocol, and a commentator with an affiliate relationship to the product they are discussing.

None of these is disqualifying. All of them are relevant, and the last one is close to universal in consumer longevity content, including on sites that also publish honest work.

Our own conflict, stated

This site carries affiliate relationships. That is a commercial interest in some of the products discussed here, and it is exactly the kind of conflict this page says to weigh.

The constraints we accept are that verification runs before and independently of any commercial consideration, that an unsupported verdict is published whether or not the product is one we could earn from, and that the affiliate relationship is disclosed. Those constraints are worth precisely as much as the record of unsupported verdicts on products we could have sold, which is the thing to check rather than the promise.

How Longevity Claim Verification handles it

Funding and declared conflicts are recorded on every check and reported as a confidence adjustment rather than a disqualification. A study is never marked unsupported on funding alone, and funding is never omitted because the finding was convenient.